The central risk is that Coherent fails to convert a temporary manufacturing bottleneck into durable economics before customers, rivals, or new architectures reduce dependence on its supply. The next five years also carry meaningful
capex, concentration, and cycle risk: if Sherman under-runs, AI optics digests, or supply normalizes faster than expected, revenue can still grow while margins and the
valuation multiple compress.